Oldbeta-XL 25 Tablet contains Metoprolol Succinate 23.75 mg, a cardioselective beta-1 adrenergic receptor blocker primarily used in the management of cardiovascular conditions. It is indicated for the treatment of hypertension, angina pectoris, and heart failure, as well as for the prevention of myocardial infarction and reduction of cardiovascular mortality in patients with established coronary artery disease. Metoprolol Succinate exerts its therapeutic effects by selectively blocking beta-1 receptors in the heart, leading to decreased heart rate, myocardial contractility, and cardiac output, thereby reducing oxygen demand and workload on the heart. The extended-release formulation of Oldbeta-XL 25 ensures a sustained plasma concentration, allowing once-daily dosing and improved patient compliance. This medication should be used with caution in patients with bradycardia, hypotension, or conduction abnormalities and is contraindicated in those with severe sinus bradycardia, second- or third-degree atrioventricular block, or cardiogenic shock. Dose adjustments may be necessary in patients with hepatic impairment. Common side effects include fatigue, dizziness, and gastrointestinal disturbances. Patients should be monitored regularly for blood pressure, heart rate, and signs of worsening heart failure. Oldbeta-XL 25 Tablet should be administered under medical supervision with adherence to prescribed dosage and monitoring guidelines.

Dosage & How to Use